# LCS12 Adolescent Study

> **NCT01434160** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 304 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Skyla (Levonorgestrel, BAY86-5028)

## Key facts

- **NCT ID:** NCT01434160
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-06
- **Final completion:** 2015-05
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2015-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434160, "LCS12 Adolescent Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01434160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*